| Tocilizumab |
Influence on protein activity in tumor tissue |
Western Blot |
5.00 mg/kg |
UM-HMC-3B (xenograft) |
Mus musculus |
C.B-17 scid |
|
|
| Tocilizumab |
Influence on protein activity |
Western Blot |
0.00 µM |
UM-HMC-1 |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on protein activity |
Western Blot |
0.01 µM |
UM-HMC-1 |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on protein activity |
Western Blot |
0.10 µM |
UM-HMC-1 |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on protein activity in presence of rhIL-6 |
Western Blot |
0.00 µM |
UM-HMC-3B |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on protein activity in presence of rhIL-6 |
Western Blot |
0.01 µM |
UM-HMC-3B |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on protein activity in presence of rhIL-6 |
Western Blot |
0.10 µM |
UM-HMC-3B |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on protein activity in presence of conditionend medium |
Western Blot |
0.00 µM |
UM-HMC-3B |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on protein activity in presence of conditionend medium |
Western Blot |
0.01 µM |
UM-HMC-3B |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on protein activity in presence of conditionend medium |
Western Blot |
0.10 µM |
UM-HMC-3B |
Homo sapiens |
|
|
|
